Evozyne Alternatives & Competitors
12 companies similar to Evozyne — Evozyne designs novel therapeutic proteins with generative AI to solve immunolog...
Companies similar to Evozyne
AQEMIA
Scale drug discovery with quantum-inspired physics and generative AI
Manifold Bio
Organism-scale intelligence, designed in vivo
Generate:Biomedicines
Pioneering generative biology to create breakthrough therapeutics.
ProFound Therapeutics
Pioneering the expanded human proteome to reveal a universe of new medicines.
Rival Readout
Competing with Evozyne? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Differentiated Therapeutics Inc
What if you could predict molecules to make the cause of disease disappear?
KSQ Therapeutics, Inc.
The company is deploying CRISPRomics for novel drug development across broad therapeutic a...
Promatix Biosciences Ltd
Using multi-omics to develop the next generation of cancer therapeutics
Versameb AG
The next generation of RNA therapeutics
Insilico Medicine
#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLM...
Cullgen Inc.
Powering protein degradation for tomorrow's medicines
Synbio Technologies
Changing the world, one sequence at a time.
About Evozyne
Evozyne, founded in 2020, is at the forefront of the Biotechnology and Pharmaceutical industries with its innovative approach to drug development. The company's slogan, "Generative AI-powered drug discovery platform and product development," encapsulates its mission to design novel protein therapeutics that meet previo...
AI-native Protein Design, Protein Synthesis and Testing, Therapeutic Protein Development, Immunology Pipeline Advancement
Patients with High Unmet Need in Immune-Mediated Diseases, Healthcare Providers, Pharmaceutical Companies
Generative AI, Drug Discovery, Protein Design, Therapeutic Discovery, Molecular Scale, Novel Protein Therapeutics, Healthcare Innovation, AI In Drug Development, Complex Challenges, Protein Engineering, Societal Challenges Solution
B2B, B2D
Licensing, Performance Based, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Evozyne: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Evozyne on 15 Jun 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.